Status:
COMPLETED
Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients
Lead Sponsor:
AstraZeneca
Conditions:
Compliance
Gastroprotector Therapy
Eligibility:
All Genders
18+ years
Brief Summary
Prospective multicentric study to evaluate the compliance of gastroprotective treatment in NSAID patients at risk of GI complications. Secondary objectives: To identify the factors associated to treat...
Eligibility Criteria
Inclusion
- Signed informed consent
- Patients consulting to the specialized care clinics who have been prescribed NSAID and gastroprotection for at least 15 days following standard clinical practice.
Exclusion
- Any gastroprotective treatment prescribed for other condition than NSAID-related gastrointestinal event prevention
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT00699725
Start Date
May 1 2008
End Date
January 1 2009
Last Update
December 7 2010
Active Locations (128)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Vitoria-Gasteiz, Alava, Spain
2
Research Site
Albacete, Albacete, Spain
3
Research Site
Alacant / Alicante, Alicante, Spain
4
Research Site
Alcoy, Alicante, Spain